微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | -3% | -53.06% | -43.54% | 127/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | -2.09% | -45.14% | -194.37% | 125/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | -0.71% | -208.7% | 86.35% | 123/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | -5.2% | -200.58% | -165.31% | 113/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | -1.96% | -1052.94% | -36.11% | 115/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -1.44% | -188% | -526.09% | 117/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -0.23% | -276.92% | 86.71% | 114/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -1.73% | -111.09% | -917.65% | 107/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -0.17% | -100.83% | 66% | 114/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -0.5% | -102.52% | -484.62% | 117/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.13% | -99.35% | -99.17% | 112/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 15.6% | -30.39% | -23.94% | 9/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 20.51% | 114.76% | 3.22% | 1/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 19.87% | 365.34% | -0.2% | 1/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 19.91% | 677.73% | -11.16% | 1/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 22.41% | 119.71% | 134.66% | 4/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 9.55% | -21.53% | 123.65% | 32/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.27% | -57.34% | 66.8% | 57/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.56% | 2% | -74.9% | 50/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 10.2% | -57.83% | -16.19% | 41/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 12.17% | 2% | 21.58% | 19/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 10.01% | -18.42% | -58.62% | 15/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 24.19% | 42.8% | 97.15% | 13/159 | 3.82% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | 12.27% | 43.68% | -27.57% | 12/159 | 4.28% | 哈三联 | 27.17% | 行业排名> |
| 2019-12-31 | 16.94% | -21.94% | -21.94% | 28/159 | 2.62% | 汇宇制药 | 55.94% | 行业排名> |
| 2018-12-31 | 21.7% | 68.48% | 154.1% | 12/159 | 7.16% | 中哲精化 | 45.32% | 行业排名> |
| 2018-06-30 | 8.54% | 86.06% | -33.7% | 14/159 | 4.62% | 汇宇制药 | 31.9% | 行业排名> |
| 2017-12-31 | 12.88% | 898.45% | 180.61% | 30/159 | 9.61% | 誉衡药业 | 35.56% | 行业排名> |
| 2017-06-30 | 4.59% | 2% | 255.81% | 48/159 | 5.55% | 奥赛康 | 35% | 行业排名> |
| 2016-12-31 | 1.29% | 2% | 2% | 96/159 | 6.11% | 奥赛康 | 28.15% | 行业排名> |